TCI Wealth Advisors’s Ligand Pharmaceuticals LGND Stock Holding History

TCI Wealth Advisors’s Portfolio LGND Stock Details LGND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-39	Closed	-$2.87K	–	1315
2023 Q1	$2.87K	Hold	39	–	–	﹤0.01%	1872
2022 Q4	$2.6K	Sell	39 -24	-38%	-$1.56K	﹤0.01%	1909
2022 Q3	$3K	Hold	63	–	–	﹤0.01%	1790
2022 Q2	$3K	Buy	+63	New	+$3.58K	﹤0.01%	1829
2022 Q1	–	Sell	-69	Closed	-$7K	–	2347
2021 Q4	$7K	Buy	69 +6	+10%	+$554	﹤0.01%	1432
2021 Q3	$5K	Buy	63 +17	+37%	+$1.31K	﹤0.01%	1615
2021 Q2	$4K	Buy	+46	New	+$3.83K	﹤0.01%	1593
2020 Q1	–	Sell	-19	Closed	-$1K	–	1643
2019 Q4	$1K	Hold	19	–	–	﹤0.01%	1372
2019 Q3	$1K	Sell	19 -10	-34%	-$628	﹤0.01%	1322
2019 Q2	$2K	Hold	29	–	–	﹤0.01%	1028
2019 Q1	$2K	Hold	29	–	–	﹤0.01%	1042
2018 Q4	$2K	Hold	29	–	–	﹤0.01%	1012
2018 Q3	$5K	Hold	29	–	–	﹤0.01%	796
2018 Q2	$4K	Hold	29	–	–	﹤0.01%	855
2018 Q1	$3K	Hold	29	–	–	﹤0.01%	861
2017 Q4	$2K	Hold	29	–	–	﹤0.01%	1025
2017 Q3	$2K	Hold	29	–	–	﹤0.01%	964
2017 Q2	$2K	Hold	29	–	–	﹤0.01%	998
2017 Q1	$2K	Hold	29	–	–	﹤0.01%	948
2016 Q4	$2K	Sell	29 -14	-33%	-$883	﹤0.01%	1023
2016 Q3	$3K	Hold	43	–	–	﹤0.01%	869
2016 Q2	$3K	Hold	43	–	–	﹤0.01%	842
2016 Q1	$3K	Buy	+43	New	+$2.61K	﹤0.01%	847
2014 Q3	–	Sell	-119	Closed	-$5K	–	898
2014 Q2	$5K	Hold	119	–	–	﹤0.01%	588
2014 Q1	$5K	Hold	119	–	–	﹤0.01%	553
2013 Q4	$4K	Hold	119	–	–	﹤0.01%	595
2013 Q3	$3K	Hold	119	–	–	﹤0.01%	582
2013 Q2	$3K	Buy	+119	New	+$2.14K	﹤0.01%	538

Other funds holding LGND

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

SDJVC

St. Denis J. Villere & Co New Orleans, Louisiana $907M AUM 10.61% 1-Year Est. Return

SIMG

Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return

Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return

TCI Wealth Advisors's LGND Position: Q2 2023 in Review

TCI Wealth Advisors sold out of Ligand Pharmaceuticals (LGND) in Q2 2023, closing a stake of 39 shares — an estimated $2.87K sold.

TCI Wealth Advisors first reported a position in LGND in Q2 2013 and held it in 28 quarters. The position peaked at $7K in Q4 2021. 204 funds tracked by Wall St. Rank hold LGND as of Q2 2023.

TCI Wealth Advisors reported no remaining Ligand Pharmaceuticals position as of Q2 2023 after selling out during the quarter.
TCI Wealth Advisors sold 39 Ligand Pharmaceuticals shares in Q2 2023, an estimated $2.87K.
TCI Wealth Advisors first reported a position in Ligand Pharmaceuticals in Q2 2013 and held it in 28 quarters.
TCI Wealth Advisors's Ligand Pharmaceuticals position peaked at $7K in Q4 2021.
204 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q2 2023.

Based on TCI Wealth Advisors's 13F filing for Q2 2023, filed 4 Aug 2023.